Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()

The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovesti, Miriam, Zucchi, Alfredo, Feliciani, Claudio, Satolli, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441514/
https://www.ncbi.nlm.nih.gov/pubmed/34261602
http://dx.doi.org/10.1016/j.abd.2020.08.025
_version_ 1783752883781500928
author Rovesti, Miriam
Zucchi, Alfredo
Feliciani, Claudio
Satolli, Francesca
author_facet Rovesti, Miriam
Zucchi, Alfredo
Feliciani, Claudio
Satolli, Francesca
author_sort Rovesti, Miriam
collection PubMed
description The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod.
format Online
Article
Text
id pubmed-8441514
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-84415142021-09-20 Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()() Rovesti, Miriam Zucchi, Alfredo Feliciani, Claudio Satolli, Francesca An Bras Dermatol Case Report The paper presents a case of lentigo maligna melanoma of the scalp in an elderly patient treated for the nodular part with surgery and the residual melanoma in situ with 5% Imiquimod and subsequently with 3.75% Imiquimod (each concentration for 4 months, 5 times per week), with complete regression of the lesion. 3.75% Imiquimod, which is already used for the treatment of actinic keratosis, could be a useful weapon with the same effectiveness and fewer side effects compared to 5% Imiquimod. Sociedade Brasileira de Dermatologia 2021 2021-07-12 /pmc/articles/PMC8441514/ /pubmed/34261602 http://dx.doi.org/10.1016/j.abd.2020.08.025 Text en © 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Rovesti, Miriam
Zucchi, Alfredo
Feliciani, Claudio
Satolli, Francesca
Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
title Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
title_full Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
title_fullStr Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
title_full_unstemmed Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
title_short Case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% Imiquimod()()
title_sort case of large lentigo maligna melanoma of the scalp treated with 5% and 3.75% imiquimod()()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441514/
https://www.ncbi.nlm.nih.gov/pubmed/34261602
http://dx.doi.org/10.1016/j.abd.2020.08.025
work_keys_str_mv AT rovestimiriam caseoflargelentigomalignamelanomaofthescalptreatedwith5and375imiquimod
AT zucchialfredo caseoflargelentigomalignamelanomaofthescalptreatedwith5and375imiquimod
AT felicianiclaudio caseoflargelentigomalignamelanomaofthescalptreatedwith5and375imiquimod
AT satollifrancesca caseoflargelentigomalignamelanomaofthescalptreatedwith5and375imiquimod

Ejemplares similares